Opinion: Self-injectable drugs could lower healthcare costs
Houston Chronicle, December 7, 2012
In 2011, the national health care budget in the United States was estimated to have reached $2.7 trillion. Total Medicare expenditures were $549 million. This spiraling cost of care is forcing health care experts to look for ways to reduce health care costs. A very simple cost-saving measure that has received little attention is to increase the number of self-injectable drugs eligible for reimbursement by Medicare. Unfortunately, Medicare will not reimburse for most such drugs unless administered in a doctor's office or hospital.
Most Viewed
Most Emailed
- Healthcare Leaders Seek Strategic Sweet Spot
- 3 Reasons Wellness Programs Fail
- CMS Issues Health Insurance Exchange Proposed Rules
- Patients Shoulder Nearly 25% of Medical Bills
- MGMA: Physician Compensation Increasingly Based on Quality Measures
- ACOs Widespread, Yet Challenged
- Physician Pay Will Soon Depend on Outcomes
- HFMA: Patient Financial Interaction Guidelines Sharpened
- Data Collaborative Taps Predictive Analytics to Coordinate Care
- HFMA: Revenue Cycle, Reimbursements Share the Spotlight
